Project 2- Scammell
项目2-Scammell
基本信息
- 批准号:9096141
- 负责人:
- 金额:$ 42.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至
- 项目状态:未结题
- 来源:
- 关键词:AcetylcholineAcuteAddressAffectAmericanAnatomyArousalBehaviorBehavioralBrainCarbon DioxideCellsDataElectroencephalographyElectrophysiology (science)FrequenciesGlutamatesGoalsHourHypercapniaHypertensionImpaired cognitionIn Situ HybridizationKnowledgeLateralLeadLifeMapsMediatingMethodsMidline Thalamic NucleiModelingNerveNeuronsObstructive Sleep ApneaPathway interactionsPatientsPedunculopontine Tegmental NucleusPlayPopulationREM SleepResearch PersonnelResourcesRespirationRoleSleepSleep Apnea SyndromesSleep DisordersSubstantia InnominataSynapsesTechniquesWakefulnessadeno-associated viral vectorbasal forebrainbasebehavioral responsebenefit sharingcholinergicdesigner receptors exclusively activated by designer drugsexperiencegamma-Aminobutyric Acidimprovedmedical complicationmouse modelmultidisciplinaryneurochemistryneuromechanismnovel therapeuticsoptogeneticsparabrachial nucleusprogramsresearch studyrespiratoryresponsetherapy development
项目摘要
Scammell Project Summary
In patients with obstructive sleep apnea (OSA), arousals play a life-saving role,
and we hypothesize that neurons in the laterodorsal and pedunculopontine tegmental
nuclei (LDT/PPT) play an essential role in many aspects of arousal, including arousals
from sleep in OSA. Our goals are to determine the specific functions of the LDT/PPT
neurons producing acetylcholine, glutamate and GABA; to map the anatomic projections
of these cells; and to examine how they influence the activity of key target regions that
regulate sleep/wake behavior and respiration. We will pursue these goals using
optogenetics to examine acute, brief increases or decreases in neuronal activity within a
behavioral state, and pharmacosynthetics using Designer Receptors Exclusively
Activated by Designer Drugs (DREADDs) to examine changes lasting hours. As a model
of OSA, many experiments will use the Repetitive CO2 Arousal (RCA) method to
examine responses to hypercapnia during sleep.
To determine if specific LDT/PPT neurons are sufficient for wakefulness, EEG
activation, and the response to RCA, we will activate each class of neurons using the
hM3 DREADD or channelrhodopsin (ChR2). To determine if specific LDT/PPT neurons
are necessary for wakefulness, EEG activation, and the response to RCA, we will inhibit
each class of neurons using the hM4 DREADD or ArchT, an inhibitory archaerhodopsin.
To define the key LDT/PPT target regions mediating these behavioral responses, we will
map projections of specific LDT/PPT neurons using conditional anterograde and
retrograde tracing; determine which projections form functional synapses using ChR2-
Assisted Circuit Mapping (CRACM); and determine which target regions are functionally
most important by focally stimulating or inhibiting glutamatergic and cholinergic nerve
terminals in each target region using ChR2 or ArchT.
Collectively, these multidisciplinary experiments will define the neural
mechanisms through which specific types of LDT/PPT neurons promote wakefulness,
cortical activation, and arousals in a mouse model of OSA. The results of these
experiments should substantially improve our scientific knowledge of the neural
mechanisms that generate wakefulness and arousals due to hypercapnia, and ultimately
lead to better treatments for obstructive sleep apnea.
Scammell项目摘要
在阻塞性睡眠呼吸暂停(OSA)患者中,唤醒起着挽救生命的作用,
我们假设背外侧和脚桥被盖的神经元
核团(LDT/PPT)在觉醒的许多方面起着重要作用,包括觉醒
从睡眠中醒来我们的目标是确定LDT/PPT的具体功能
产生乙酰胆碱、谷氨酸和GABA的神经元;绘制解剖投影
研究这些细胞的活性,并研究它们如何影响关键靶区域的活性,
调节睡眠/觉醒行为和呼吸。我们将通过以下方式实现这些目标:
光遗传学检查急性,短暂的增加或减少神经元活动内,
行为状态和药物合成,仅使用设计者受体
由Designer Drugs(DREADDs)激活,以检查持续数小时的变化。为模特
许多实验将使用重复CO2唤醒(RCA)方法,
检查睡眠时对高碳酸血症的反应。
为了确定特定的LDT/PPT神经元是否足以用于觉醒,EEG
激活,以及对RCA的反应,我们将使用
hM 3 DREADD或通道视紫红质(ChR 2)。为了确定特定的LDT/PPT神经元是否
是清醒、脑电图激活和对RCA的反应所必需的,我们将抑制
每类神经元使用hM 4 DREADD或ArchT,一种抑制性古视紫红质。
为了定义介导这些行为反应的关键LDT/PPT靶区域,我们将
使用条件性顺行和逆行标记特定LDT/PPT神经元的映射投影,
逆行追踪;使用ChR 2确定哪些投射形成功能性突触-
辅助电路映射(CRACM);并确定哪些目标区域在功能上
最重要的是通过局部刺激或抑制多巴胺能和胆碱能神经
在每个目标区域中使用ChR 2或ArchT。
总的来说,这些多学科的实验将定义神经
特定类型的LDT/PPT神经元促进觉醒的机制,
皮质激活和觉醒。的结果予以
实验应该大大提高我们的科学知识的神经
由于高碳酸血症而产生觉醒和觉醒的机制,
从而更好地治疗阻塞性睡眠呼吸暂停。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS E SCAMMELL其他文献
THOMAS E SCAMMELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS E SCAMMELL', 18)}}的其他基金
Sleep disturbance as a risk factor for developing chronic pain
睡眠障碍是发生慢性疼痛的危险因素
- 批准号:
8368585 - 财政年份:2012
- 资助金额:
$ 42.02万 - 项目类别:
Sleep disturbance as a risk factor for developing chronic pain
睡眠障碍是发生慢性疼痛的危险因素
- 批准号:
8680211 - 财政年份:2012
- 资助金额:
$ 42.02万 - 项目类别:
Sleep disturbance as a risk factor for developing chronic pain
睡眠障碍是发生慢性疼痛的危险因素
- 批准号:
8517093 - 财政年份:2012
- 资助金额:
$ 42.02万 - 项目类别:
Wakefulness and Forebrain Activation by Orexin Neurons
食欲素神经元的觉醒和前脑激活
- 批准号:
8243531 - 财政年份:2011
- 资助金额:
$ 42.02万 - 项目类别:
Wakefulness and Forebrain Activation by Orexin Neurons
食欲素神经元的觉醒和前脑激活
- 批准号:
7798783 - 财政年份:2010
- 资助金额:
$ 42.02万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 42.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 42.02万 - 项目类别:
Operating Grants